Get the latest MLNM - Millennium Pharmaceuticals Inc. stock market performance data and financial news.
Get the latest MLNM - Millennium Pharmaceuticals Inc. together with stock market performance data and financial news.
Read Jim Cramer's take on Millennium Pharmaceuticals Inc. (MLNM) and get his latest thoughts on the company?s performance and outlook
... Millennium Pharmaceutical (MLNM / Nasdaq) Lehman Bros Widening our loss estimates
to $0.98 per share in 2002 and $0.95 for next year, to match the company's ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
... Millennium Pharmaceuticals (MLNM-Nasdaq) reports pro forma net loss of 7 cents per
share in the second quarter on $121.7 million in total revenue – both ...
http://www.thestreet.com/p/dps/cc/20030722/columnistconversation2.html
... Millennium Pharmaceuticals (MLNM-Nasdaq) reports pro forma net loss of 7 cents per
share in the second quarter on $121.7 million in total revenue – both ...
The largest overseas acquisition by a Japanese drug maker comes at a 53% premium to Millennium's Wednesday close.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10411425/1/japans-takeda-will-pay-9b-for-millennium.html
Eyetech rises.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10229230/1/health-stocks-in-motion.html
Geron rises on Merck licensing deal.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10232973/1/health-stocks-in-motion.html
Connect with TheStreet